# Tilray Brands Inc. (TLRY) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Pharmaceuticals. Price $2.65, market value $392 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Tilray Brands Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.20**. A PEG of 0.20 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.4×**. Each dollar of revenue is priced at 0.4×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.2×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.

## Profitability
- **Gross margin: 29.1%**. Tilray Brands Inc. keeps 29.1% of revenue after the direct cost of what it sells.
- **Operating margin: -9.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -13.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -7.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -4.6%**. Return on all capital, debt included, is -4.6%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -7.1%**. Each dollar of assets produces -7.1% of profit.

## Growth
- **Revenue growth (1 yr): 11.5%** (3-yr 13.4%/yr, 5-yr 12.3%/yr). Revenue grew 11.5% over the last year, against 12.3% a year compounded over five years.
- **EPS growth (1 yr): 95.6%**. Earnings per share rose 95.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.08**. Debt is 0.08 times equity: a conservative balance sheet.
- **Current ratio: 2.21** (quick 2.21). Current assets cover the next year's liabilities 2.21 times.
- **Altman Z-score: 1.82**. A Z-score of 1.82 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Tilray Brands Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (9 analysts). 9 analysts cover Tilray Brands Inc.; the consensus is buy, with an average price target of $5.72 (+116% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -79.8%** (YTD -70.7%, 3-mo -42.9%). The shares are down 79.8% over twelve months including dividends.
- **From 52-week high: -83.1%** (6.4% above the low). Trading 83% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 27**. An RSI of 27 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 1.70** (volatility 81%). Beta of 1.70 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TLRY · Page: https://foliofundamentals.com/stocks/tlry

Not investment advice.